Innovent Biologics is pivoting to R&D and oncology growth in China, but high valuation and risks temper upside. Read why ...

Osteoarthritis is a chronic, degenerative joint condition marked by the progressive deterioration of joint tissues. It is the ...

Psilocybin, the active compound in "magic mushrooms," has seen a surge in medical research over the past few years, ...

Controlling weight and cardiovascular risk factors is paramount in type 2 diabetes management; however, the definition and ...

So far, many food and drink businesses have been sceptical that weight-loss drugs will have any major impact on them. But new ...

Worldwide Healthcare Trust PLC - Annual Financial Report PR Newswire LONDON, United Kingdom, June 11 10 June 2025Worldwide Healthcare Trust PLC(the "Company") Annual Financial ...

A study by the Evernorth Research Institute looking at national prescription drug use trends found GLP-1 use between 2023-2024 rose 84.6% in Gen Alpha (ages 14 and younger). The age group was ...

ASCO Data Shows New Therapy Keeps Myeloma Patients in Remission for 5+ Years. Here's what you need to know about the ...

Veru's pivot with enobosarm: groundbreaking Phase 2b results enhance GLP-1 therapy outcomes. A positive launch could yield peak sales in billions. See more on VERU.

In a matched group of more than 170,000 adults, those treated with GLP-1 agonists had a lower risk of developing an obesity-related cancer over a median follow-up of about 4 years when compared ...